(Q28369525)
(Redirected from Q58211794)
English
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials
scientific article published on 30 June 1999
- Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials
Statements
Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials (English)
0 references
Broad Antitumor and Antiangiogenic Activities of AG3340, a Potent and Selective MMP Inhibitor Undergoing Advanced Oncology Clinical Trials (English)
0 references
30 June 1999
0 references
June 1999
0 references
878
0 references
236-70
0 references
236-270
0 references
1 INHIBITION OF
0 references